冠昊生物(300238.SZ):擬向相關銀行申請不超7億元綜合授信額度
格隆匯 3 月 8日丨冠昊生物(300238.SZ)公佈,公司於2021年3月5日召開第五屆董事會第六次會議審議通過《關於公司2021年度申請銀行綜合授信額度的議案》,現將相關公吿內容如下:根據公司2021年經營計劃安排,為了滿足公司生產經營所需的資金需求,公司擬向相關銀行申請不超過人民幣7億元的綜合授信額度,綜合授信額度不等於公司(含子公司)的實際融資金額,實際融資金額應在綜合授信額度內,以銀行與公司(含子公司)實際發生的融資金額為準,各銀行實際授信額度可在總額度範圍內進行調劑,授信期限不超過一年,自公司與銀行簽訂協議之日起計算,授信期限內授信額度可循環使用。
上述綜合授信總額內的單筆融資不再上報董事會或股東大會審議,董事會授權公司法定代表人或法定代表人指定的授權代理人在上述授信額度內代表公司辦理相關手續,並簽署上述授信額度內的一切授信(包括但不限於授信、借款、融資、抵押、質押、擔保等)有關的合同、協議、憑證等各項法律文件。
上述事項尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.